Log in

Start Your Membership Now

Johnson & Johnson (J&J) recently accepted a $2.1 billion offer from Platinum Equity for its LifeScan diabetes unit. Platinum Equity is a global firm specializing in mergers, acquisitions, and operations of companies that provide mission-critical products, services, and solutions.

With sales of its diabetes product companies falling over the past several years, J&J has previously stated it was exploring business options. It is expected that the deal will close by the end of the year. LifeScan generated about $1.5 billion in revenue during 2017.

Johnson & Johnson is an American multinational medical devices . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Tagged As: